info@auctorespublishing.com
+1-(302)-520-2644
+1-(302)-520-2644
Chat with us

Role of Heme Oxygenase-1 in Sickle Cell Anemia-Related Oxidative Stress: A Narrative Review

  1. Home
  2. Journals
  3. General Medicine and Clinical Practice
  4. Archives
Submit Guidelines

Review Article | DOI: https://doi.org/10.31579/2639-4162/222

Role of Heme Oxygenase-1 in Sickle Cell Anemia-Related Oxidative Stress: A Narrative Review

  • Emmanuel Ifeanyi Obeagu

Emmanuel Ifeanyi Obeagu, Department of Medical Laboratory Science.

*Corresponding Author: Adrian Emmanuel Ifeanyi Obeagu, Department of Medical Laboratory Science.

Citation: Emmanuel I. Obeagu, (2024), Role of Heme Oxygenase-1 in Sickle Cell Anemia-Related Oxidative Stress: A Narrative Review, J. General Medicine and Clinical Practice, 7(16); DOI:10.31579/2639-4162/222

Copyright: © 2024, Emmanuel Ifeanyi Obeagu. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 02 September 2024 | Accepted: 18 September 2024 | Published: 27 September 2024

Keywords: sickle cell anemia; heme oxygenase-1; oxidative stress; antioxidant defense; therapeutic strategies

Abstract

Sickle Cell Anemia (SCA) is a genetic disorder characterized by the production of hemoglobin S, leading to chronic hemolysis, vaso-occlusive crises, and elevated oxidative stress. Heme oxygenase-1 (HO-1), an enzyme responsible for the breakdown of heme, plays a critical role in mitigating oxidative stress by converting heme into biliverdin, iron, and carbon monoxide (CO). This narrative review explores the role of HO-1 in the context of SCA-related oxidative stress, focusing on its mechanisms of action, interactions with oxidative stress pathways, and potential therapeutic implications. HO-1’s ability to reduce oxidative damage and inflammation highlights its significance as a therapeutic target for managing the oxidative burden in SCA. In SCA, the breakdown of sickled red blood cells (RBCs) releases free heme, which contributes to oxidative stress and inflammation. HO-1 helps counteract these effects by catalyzing the degradation of heme and producing antioxidant by-products such as bilirubin. Bilirubin and CO exhibit protective properties, including ROS scavenging and anti-inflammatory effects, which are crucial for managing oxidative stress and maintaining vascular health. Additionally, HO-1’s role in regulating iron availability and modulating inflammatory pathways further underscores its protective functions in SCA.

Introduction

Sickle Cell Anemia (SCA) is a severe, inherited blood disorder characterized by the presence of hemoglobin S (HbS), which causes red blood cells (RBCs) to adopt a rigid, sickle-shaped form under low oxygen conditions. This morphological change leads to chronic hemolysis, vaso-occlusive crises, and widespread inflammation. One of the key pathological features of SCA is oxidative stress, which arises from the breakdown of sickled RBCs and the subsequent release of free hemoglobin and heme into the bloodstream. This review focuses on heme oxygenase-1 (HO-1), an enzyme that plays a critical role in managing oxidative stress by degrading heme into non-toxic by-products. [1-5] Heme oxygenase-1 (HO-1) is an inducible enzyme responsible for the catabolism of heme, a pro-oxidant molecule, into biliverdin, free iron, and carbon monoxide (CO). The process of heme degradation is crucial in reducing oxidative stress, as it removes heme from the circulation, thus preventing its contribution to oxidative damage. Biliverdin, which is subsequently converted to bilirubin, exhibits strong antioxidant properties and helps protect cells from oxidative injury. CO, a by-product of HO-1 activity, has been shown to have anti-inflammatory effects and can modulate vascular tone. These actions collectively contribute to reducing oxidative stress and inflammation, which are prevalent in SCA. [6-10]In the context of SCA, elevated oxidative stress has several detrimental effects on cellular function and overall health. The sickling of RBCs leads to the release of free heme, which exacerbates oxidative damage and contributes to inflammation. The excessive generation of reactive oxygen species (ROS) results in cellular damage, reduced nitric oxide availability, and endothelial dysfunction. This environment promotes the progression of vaso-occlusive crises and further complicates the management of the disease. HO-1 helps mitigate these effects by breaking down free heme and thereby reducing oxidative stress. [11-15]

HO-1 is regulated by various signaling pathways that respond to oxidative stress. The expression of HO-1 is typically upregulated in response to high levels of ROS, acting as a cellular defense mechanism. The enzyme's induction is mediated through transcription factors such as nuclear factor erythroid 2-related factor 2 (Nrf2), which regulates the expression of several antioxidant and cytoprotective genes. Understanding these regulatory mechanisms is essential for developing therapeutic strategies aimed at enhancing HO-1 activity to manage oxidative stress in SCA. [16-20] The protective effects of HO-1 extend beyond its antioxidant activity. The enzyme's role in iron metabolism is significant, as it sequesters free iron released during heme degradation, preventing it from catalyzing further oxidative reactions. Additionally, HO-1-derived CO has been shown to have anti-inflammatory effects, which are beneficial in reducing the chronic inflammation characteristic of SCA. By modulating these pathways, HO-1 contributes to the overall reduction in disease severity and improvement in patient outcomes. [21-25] Given the critical role of HO-1 in managing oxidative stress and inflammation, it presents a promising target for therapeutic interventions in SCA. Pharmacological agents that induce HO-1 expression or mimic its effects could potentially provide relief from the oxidative burden and inflammation associated with the disease. Similarly, gene therapy approaches aimed at enhancing HO-1 activity may offer novel treatment options for patients with SCA. [26-30]

Role of Heme Oxygenase-1 in Oxidative Stress

Heme oxygenase-1 (HO-1) plays a critical role in managing oxidative stress through its ability to degrade heme, a potent pro-oxidant. The primary function of HO-1 is to catalyze the breakdown of heme into biliverdin, free iron, and carbon monoxide (CO). This process not only reduces the availability of free heme—thereby mitigating its pro-oxidant effects—but also generates by-products that exert antioxidant and anti-inflammatory properties. [31-33] The breakdown of heme by HO-1 results in the production of biliverdin, which is subsequently converted to bilirubin. Both biliverdin and bilirubin have well-documented antioxidant properties. Bilirubin, in particular, is a potent scavenger of reactive oxygen species (ROS) and has been shown to protect cells from oxidative damage. By converting heme into these less harmful products, HO-1 effectively reduces the oxidative load on cells, protecting them from damage associated with excessive ROS. [34-38] Free heme breakdown also releases free iron into the circulation. However, the excess iron can catalyze further oxidative reactions through the Fenton reaction, exacerbating oxidative stress. HO-1 mitigates this risk by sequestering the released iron in a form that is less available for oxidative reactions. This regulation of iron homeostasis helps to prevent iron-induced oxidative damage and maintains cellular integrity. [39-42] Carbon monoxide (CO), another by-product of heme degradation by HO-1, has several beneficial effects related to oxidative stress. CO acts as a signaling molecule with anti-inflammatory properties and can modulate vascular tone. It has been shown to reduce the production of pro-inflammatory cytokines and prevent the activation of inflammatory pathways. By modulating these processes, CO contributes to the reduction of oxidative stress and inflammation. [43-46]HO-1 induction is part of a broader cellular response to oxidative stress. The enzyme's expression ais regulated by transcription factors such as nuclear factor erythroid 2-related factor 2 (Nrf2), which also upregulates other antioxidant and cytoprotective genes. This coordinated response enhances the cell's overall ability to manage oxidative stress and reduce damage caused by ROS.47 In various disease contexts, including Sickle Cell Anemia (SCA), the role of HO-1 becomes particularly significant. In SCA, the breakdown of sickled red blood cells releases large amounts of heme, contributing to oxidative stress and inflammation. HO-1’s ability to degrade heme and produce antioxidant by-products is crucial in mitigating these effects and protecting against the complications associated with SCA, such as vaso-occlusive crises and tissue damage.48

Mechanisms of HO-1 Action in Sickle Cell Anemia

Heme oxygenase-1 (HO-1) is a key enzyme in the body's response to oxidative stress, and its role is particularly significant in Sickle Cell Anemia (SCA), where it helps modulate the adverse effects of oxidative damage. The mechanisms through which HO-1 exerts its protective effects in SCA are multifaceted, involving the degradation of heme, modulation of oxidative stress, regulation of inflammation, and interaction with iron metabolism.49 HO-1 catalyzes the degradation of heme, a process that transforms heme into biliverdin, free iron, and carbon monoxide (CO). This reaction is crucial for managing oxidative stress in SCA because free heme, released from lysed sickled red blood cells (RBCs), can contribute to the production of reactive oxygen species (ROS) through Fenton reactions. By converting heme into biliverdin and subsequently into bilirubin, HO-1 helps neutralize excess ROS. Bilirubin, a potent antioxidant, scavenges ROS and reduces oxidative damage to cells and tissues. This antioxidant activity is essential in counteracting the oxidative stress resulting from chronic hemolysis and vaso-occlusive events in SCA.[50] Another significant mechanism of HO-1 action in SCA is its role in regulating iron homeostasis. The degradation of heme by HO-1 releases free iron, which can catalyze the formation of ROS through Fenton chemistry if not properly sequestered. HO-1 mitigates this risk by promoting the sequestration of free iron in ferritin or binding it to transferrin, thus preventing the excess iron from contributing to further oxidative stress. By controlling iron levels and reducing the potential for iron-induced oxidative damage, HO-1 helps protect cells from the detrimental effects of oxidative stress and inflammation. [51]HO-1 also influences inflammation through its by-products. Carbon monoxide (CO), produced during heme degradation, has been shown to have anti-inflammatory effects. CO can modulate the activity of inflammatory cells and reduce the expression of pro-inflammatory cytokines. In SCA, chronic inflammation is a significant issue, exacerbating the disease's symptoms and complications. By reducing the production of inflammatory cytokines and mitigating inflammatory responses, HO-1 helps alleviate the inflammatory component of SCA and contributes to overall disease management.[52]

HO-1's ability to influence the cellular redox state is another critical aspect of its function. The enzyme's activity helps to maintain a balance between oxidative and reductive processes within cells. By reducing the levels of pro-oxidant heme and enhancing the production of antioxidant by-products, HO-1 stabilizes the cellular redox environment. This stabilization is particularly important in SCA, where the chronic oxidative stress from sickled RBCs and hemolysis can overwhelm cellular defenses. HO-1's modulation of the redox state contributes to the protection of cellular components from oxidative damage and supports cellular resilience.[53] HO-1 expression is regulated by several cellular stress responses, including those mediated by the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. In SCA, oxidative stress and inflammatory signals can induce HO-1 expression as part of the cellular defense mechanism. The activation of Nrf2 leads to the transcription of HO-1 and other antioxidant genes, which collectively enhance the cell's ability to cope with oxidative damage. This induction of HO-1 is a key adaptive response that helps mitigate the harmful effects of elevated oxidative stress and inflammation in SCA.54 HO-1’s effects on vascular health are also relevant to SCA management. The enzyme's by-products, particularly CO, have vasodilatory properties that can improve blood flow and reduce the frequency of vaso-occlusive crises. By enhancing endothelial function and modulating vascular tone, HO-1 helps prevent or alleviate the blockages in blood vessels that are characteristic of SCA. This vascular protection contributes to reducing the severity of complications associated with the disease. [55]

HO-1 and the Regulation of Inflammatory Pathways

Heme oxygenase-1 (HO-1) plays a pivotal role in the regulation of inflammatory pathways, which is crucial for managing diseases characterized by chronic inflammation, such as Sickle Cell Anemia (SCA). This enzyme, through its by-products and interactions with various cellular pathways, modulates inflammatory responses and helps mitigate the adverse effects of inflammation.[56] One of the primary by-products of HO-1 activity is carbon monoxide (CO), which has well-documented anti-inflammatory properties. CO influences inflammation by interacting with various cellular signaling pathways. It can inhibit the expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) by blocking the activation of nuclear factor kappa B (NF-κB), a key transcription factor involved in inflammation. CO also reduces the production of reactive oxygen species (ROS) and limits oxidative stress, further contributing to its anti-inflammatory effects. In SCA, where chronic inflammation exacerbates disease symptoms, CO’s ability to modulate these inflammatory pathways is particularly beneficial. [57] Another by-product of HO-1 activity, bilirubin, is known for its strong antioxidant properties. Bilirubin scavenges ROS and prevents oxidative damage, thereby reducing inflammation. Elevated bilirubin levels, resulting from increased HO-1 activity, are associated with reduced levels of inflammatory markers and improved clinical outcomes in conditions with high oxidative stress. In SCA, where oxidative stress and inflammation are closely linked, the antioxidant and anti-inflammatory properties of bilirubin help alleviate some of the inflammatory damage and protect against vascular complications.[55]

HO-1 also influences immune cell function, which is critical in controlling inflammation. The enzyme affects the activity of various immune cells, including macrophages, neutrophils, and lymphocytes. HO-1 can alter macrophage polarization, promoting an anti-inflammatory M2 phenotype over the pro-inflammatory M1 phenotype. This shift helps reduce tissue damage and inflammatory responses. Additionally, HO-1 affects neutrophil activation and migration, further modulating the inflammatory process. By influencing these immune cells, HO-1 contributes to the regulation of inflammation and helps manage inflammatory conditions associated with SCA.[56] HO-1 impacts the production of cytokines, which are central to the inflammatory process. By modulating the NF-κB signaling pathway, HO-1 reduces the expression of pro-inflammatory cytokines and enhances the production of anti-inflammatory cytokines. This regulation helps balance the inflammatory response and prevent excessive inflammation, which can contribute to tissue damage and disease progression in SCA. The ability of HO-1 to modulate cytokine levels is a key aspect of its role in managing inflammation.HO-1 interacts with various immune signaling pathways to regulate inflammation. For example, the enzyme influences the activation of the Nrf2 pathway, which controls the expression of antioxidant and anti-inflammatory genes. By activating Nrf2, HO-1 promotes the transcription of genes that counteract oxidative stress and inflammation. Additionally, HO-1 affects the mitogen-activated protein kinase (MAPK) pathways, which are involved in cellular responses to stress and inflammation. These interactions highlight the enzyme’s role in integrating multiple signaling pathways to modulate inflammatory responses.[57] HO-1 also plays a role in maintaining endothelial function, which is crucial for vascular health and inflammation. The enzyme’s by-products, particularly CO, can improve endothelial cell function by reducing oxidative stress and inflammation. This protection helps prevent endothelial dysfunction, which is a key factor in the pathogenesis of vaso-occlusive crises in SCA. By supporting endothelial health, HO-1 contributes to the overall regulation of inflammation and vascular integrity.[57]

Conclusion

Heme oxygenase-1 (HO-1) plays a pivotal role in modulating inflammatory responses in Sickle Cell Anemia (SCA) through its diverse mechanisms of action. By degrading heme into biliverdin, carbon monoxide (CO), and free iron, HO-1 helps to counteract oxidative stress and inflammation, which are central to the pathophysiology of SCA. Biliverdin and its derivative bilirubin serve as potent antioxidants, reducing oxidative damage and inflammation, while CO exerts anti-inflammatory effects by interacting with key signaling pathways and reducing the production of pro-inflammatory cytokines. The enzyme's impact extends to the regulation of immune cell function and cytokine production. HO-1 influences macrophage polarization, promoting an anti-inflammatory M2 phenotype over the pro-inflammatory M1 phenotype. It also modulates the activity of other immune cells, such as neutrophils and lymphocytes, contributing to the overall balance of the inflammatory response. By affecting these cellular processes, HO-1 helps mitigate the chronic inflammation and tissue damage characteristic of SCA.

References

  1. Alenzi FQ, AlShaya DS. (2019). Biochemical and molecular analysis of the beta-globin gene on Saudi sickle cell anemia. Saudi Journal of Biological Sciences;26(7):1377-1384.
    View at Publisher | View at Google Scholar
  2. Obeagu EI, Ochei KC, Nwachukwu BN, Nchuma BO. (2015). Sickle cell anaemia: a review. Scholars Journal of Applied Medical Sciences;3(6B):224422-224452.
    View at Publisher | View at Google Scholar
  3. Obeagu EI. (2020). Erythropoeitin in Sickle Cell Anaemia: A Review. International Journal of Research Studies in Medical and Health Sciences;5(2):22-28.
    View at Publisher | View at Google Scholar
  4. Obeagu EI. Sickle Cell Anaemia: Haemolysis and Anemia. Int. J. Curr. Res. Chem. Pharm. Sci. 2018;5(10):20-21.
    View at Publisher | View at Google Scholar
  5. Obeagu EI, Muhimbura E, Kagenderezo BP, Uwakwe OS, Nakyeyune S, Obeagu GU. (2022). An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis. J Biomed Sci;11(10):84.
    View at Publisher | View at Google Scholar
  6. Sbodio JI, Snyder SH, Paul BD. (2019). Redox mechanisms in neurodegeneration: from disease outcomes to therapeutic opportunities. Antioxidants & Redox Signaling. ;30(11):1450-1499.
    View at Publisher | View at Google Scholar
  7. Kovacic P, Somanathan R. (2012). Redox processes in neurodegenerative disease involving reactive oxygen species. Current neuropharmacology;10(4):289-302.
    View at Publisher | View at Google Scholar
  8. La Rosa P, Petrillo S, Bertini ES, Piemonte F. (2020). Oxidative stress in DNA repeat expansion disorders: a focus on NRF2 signaling involvement. Biomolecules;10(5):702.
    View at Publisher | View at Google Scholar
  9. Obeagu EI, Bunu UO, Obeagu GU, Habimana JB. (2023). Antioxidants in the management of sickle cell anaemia: an area to be exploited for the wellbeing of the patients. International Research in Medical and Health Sciences;6(4):12-17.
    View at Publisher | View at Google Scholar
  10. Obeagu EI, Ogunnaya FU, Obeagu GU, Ndidi AC. (2023). Sickle cell anaemia: a gestational enigma. European Journal of Biomedical and Pharmaceutical Sciences;10((9): 72-75
    View at Publisher | View at Google Scholar
  11. Obeagu EI. (2018). An update on micro-RNA in sickle cell disease. Int J Adv Res Biol Sci; 5:157-158.
    View at Publisher | View at Google Scholar
  12. Obeagu EI, Babar Q. (2021). Covid-19 and Sickle Cell Anemia: Susceptibility and Severity. J. Clinical and Laboratory Research;3(5):2768-2487.
    View at Publisher | View at Google Scholar
  13. Obeagu EI. (2023). Depression in Sickle Cell Anemia: An Overlooked Battle. Int. J. Curr. Res. Chem. Pharm. Sci;10(10):41-42.
    View at Publisher | View at Google Scholar
  14. Renoux C, Joly P, Faes C, Mury P, Eglenen B, et all., (2018). Association between oxidative stress, genetic factors, and clinical severity in children with sickle cell anemia. The Journal of pediatrics; 195:228-235.
    View at Publisher | View at Google Scholar
  15. Gueye Tall F, Martin C, Ndour EH, Faes C, Deme Ly I, et all., (2020). Influence of oxidative stress biomarkers and genetic polymorphisms on the clinical severity of hydroxyurea-free senegalese children with sickle cell anemia. Antioxidants;9(9):863.
    View at Publisher | View at Google Scholar
  16. Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. (2021). The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. International journal of molecular sciences;22(9):4642.
    View at Publisher | View at Google Scholar
  17. Obeagu EI, Obeagu GU. (2023). Evaluation of Hematological Parameters of Sickle Cell Anemia Patients with Osteomyelitis in A Tertiary Hospital in Enugu, Nigeria. Journal of Clinical and Laboratory Research;6(1):2768-0487.
    View at Publisher | View at Google Scholar
  18. Obeagu EI, Dahir FS, Francisca U, Vandu C, Obeagu GU. (2023). Hyperthyroidism in sickle cell anaemia. Int. J. Adv. Res. Biol. Sci;10(3):81-89.
    View at Publisher | View at Google Scholar
  19. Swem CA, Ukaejiofo EO, Obeagu EI, Eluke B. (2018). Expression of micro-RNA 144 in sickle cell disease. Int. J. Curr. Res. Med. Sci;4(3):26-32.
    View at Publisher | View at Google Scholar
  20. Obeagu EI. (2018). Sickle cell anaemia: Historical perspective, Pathophysiology and Clinical manifestations. Int. J. Curr. Res. Chem. Pharm. Sci;5(11):13-15.
    View at Publisher | View at Google Scholar
  21. Obeagu EI, Obeagu GU. (2023). Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences. Jun 10;6(2):10-13.
    View at Publisher | View at Google Scholar
  22. Silva M, Faustino P. (2023). From stress to sick (le) and back again–oxidative/antioxidant mechanisms, genetic modulation, and cerebrovascular disease in children with sickle cell anemia. Antioxidants;12(11):1977.
    View at Publisher | View at Google Scholar
  23. Deng M, Sun J, Peng L, Huang Y, Jiang W, et all., (2022). Scutellarin acts on the AR-NOX axis to remediate oxidative stress injury in a mouse model of cerebral ischemia/reperfusion injury. Phytomedicine; 103:154214.
    View at Publisher | View at Google Scholar
  24. Obeagu EI, Mohamod AH. (2023). An update on Iron deficiency anaemia among children with congenital heart disease. Int. J. Curr. Res. Chem. Pharm. Sci;10(4):45-48.
    View at Publisher | View at Google Scholar
  25. Edward U, Osuorji VC, Nnodim J, Obeagu EI. (2022). Evaluationof Trace Elements in Sickle Cell Anaemia Patients Attending Imo State Specialist Hospital, Owerri. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035. Mar 4;2(1):218-234.
    View at Publisher | View at Google Scholar
  26. Umar MI, Aliyu F, Abdullahi MI, Aliyu MN, Isyaku I, Aisha BB, Sadiq RU, Shariff MI, Obeagu EI. Assessment Of Factors Precipitating Sickle Cell Crises Among Under 5-Years Children Attending Sickle Cell Clinic of Murtala Muhammad Specialist Hospital, Kano. blood.;11:16.
    View at Publisher | View at Google Scholar
  27. Obeagu EI. (2018). Vaso-occlusion and adhesion molecules in sickle cells disease. Int J Curr Res Med Sci;4(11):33-35.
    View at Publisher | View at Google Scholar
  28. Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L. (2017). Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxidative medicine and cellular longevity;(1):2525967.
    View at Publisher | View at Google Scholar
  29. Ifeanyi OE, Stella EI, Favour AA. (2018). Antioxidants In the Management of Sickle Cell Anaemia. Int J Hematol Blood Disord (Internet) (cited 2021 Mar 4); 3.
    View at Publisher | View at Google Scholar
  30. Buhari HA, Ahmad AS, Obeagu EI. (2023). Current Advances in the Diagnosis and Treatment of Sickle Cell Anaemia. APPLIED SCIENCES (NIJBAS). 4(1).
    View at Publisher | View at Google Scholar
  31. Nnodim J, Uche U, Ifeoma U, Chidozie N, Ifeanyi O, ET ALL., (2015). Hepcidin and erythropoietin level in sickle cell disease. British Journal of Medicine and Medical Research;8(3):261-265.
    View at Publisher | View at Google Scholar
  32. Obeagu EI. (2023). BURDEN OF CHRONIC OSTEOMYLITIS: REVIEW OF ASSOCIATIED FACTORS. Madonna University journal of Medicine and Health Sciences;3(1):1-6.
    View at Publisher | View at Google Scholar
  33. Obeagu EI, Obeagu GU. (2024). Oxidative Damage and Vascular Complications in Sickle Cell Anemia: A Review. Elite Journal of Haematology;2(3):58-66.
    View at Publisher | View at Google Scholar
  34. Gueye Tall F, Martin C, Ndour EH, Faes C, Deme Ly I, ET ALL., (2020). Influence of oxidative stress biomarkers and genetic polymorphisms on the clinical severity of hydroxyurea-free senegalese children with sickle cell anemia. Antioxidants;9(9):863.
    View at Publisher | View at Google Scholar
  35. Silva DG, Junior EB, de Souza Torres L, Júnior OR, et all., (2011). Bonini-Domingos CR, De Almeida EA. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia. Blood Cells, Molecules, and Diseases;47(1):23-28.
    View at Publisher | View at Google Scholar
  36. Consoli V, Sorrenti V, Grosso S, Vanella L. (2021). Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions. Biomolecules;11(4):589.
    View at Publisher | View at Google Scholar
  37. Aloh GS, Obeagu EI, Okoroiwu IL, Odo CE, Chibunna OM, et all., (2015). Antioxidant-Mediated Heinz Bodies Levels of Sickle Erythrocytes under Drug-Induced Oxidative Stress. European Journal of Biomedical and Pharmaceutical sciences;2(1):502-507.
    View at Publisher | View at Google Scholar
  38. Obeagu EI, Obeagu GU. (2023). Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences; 6 (2): 10-13.
    View at Publisher | View at Google Scholar
  39. Obeagu EI, Ogbuabor BN, Ikechukwu OA, Chude CN. (2014). Haematological parameters among sickle cell anemia patients’ state and haemoglobin genotype AA individuals at Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. International Journal of Current Microbiology and Applied Sciences;3(3):1000-1005.
    View at Publisher | View at Google Scholar
  40. Ifeanyi OE, Nwakaego OB, Angela IO, Nwakaego CC. (2014). Haematological parameters among sickle cell anaemia... Emmanuel Ifeanyi1, et al. pdf• Obeagu. Int. J. Curr. Microbiol. App. Sci;3(3):1000-1005.
    View at Publisher | View at Google Scholar
  41. Obeagu EI, Opoku D, Obeagu GU. (2023). Burden of nutritional anaemia in Africa: A Review. Int. J. Adv. Res. Biol. Sci;10(2):160-163.
    View at Publisher | View at Google Scholar
  42. Ifeanyi E. (2015). Erythropoietin (Epo) Level in Sickle Cell Anaemia (HbSS) With Falciparum Malaria Infection in University Health Services, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. PARIPEX - INDIAN JOURNAL OF RESEARCH; 4(6): 258-259
    View at Publisher | View at Google Scholar
  43. Ifeanyi OE, Nwakaego OB, Angela IO, Nwakaego CC. (2014). Haematological parameters among sickle cell anaemia patients in steady state and haemoglobin genotype AA individuals at Michael Okpara, University of Agriculture, Umudike, Abia State, Nigeria. Int. J. Curr. Microbiol. App. Sci;3(3):1000-1005.
    View at Publisher | View at Google Scholar
  44. Ifeanyi OE, Stanley MC, Nwakaego OB. (2014). Comparative analysis of some haematological parameters in sickle cell patients in steady and crisis state at michael okpara University of agriculture, Umudike, Abia state, Nigeria. Int. J. Curr. Microbiol. App. Sci;3(3):1046-1050.
    View at Publisher | View at Google Scholar
  45. Ifeanyi EO, Uzoma GO. (2020). Malaria and The Sickle Cell Trait: Conferring Selective Protective Advantage to Malaria. J Clin Med Res; 2:1-4.
    View at Publisher | View at Google Scholar
  46. Obeagu EI, Obeagu GU. (2024). Oxidative Damage and Vascular Complications in Sickle Cell Anemia: A Review. Elite Journal of Haematology; 2 (3).:58-66.
    View at Publisher | View at Google Scholar
  47. Obeagu EI, Obeagu GU. (2024). Addressing Myths and Stigmas: Breaking Barriers in Adolescent Sickle Cell Disease Education. Elite Journal of Health Science;2(2):7-15.
    View at Publisher | View at Google Scholar
  48. Obeagu EI, Obeagu GU. (2024). Implications of climatic change on sickle cell anemia: A review. Medicine. Feb 9;103(6): e37127.
    View at Publisher | View at Google Scholar
  49. Singh P, O’Toole TE, Conklin DJ, Hill BG, Haberzettl P. (2021). Endothelial progenitor cells as critical mediators of environmental air pollution-induced cardiovascular toxicity. American Journal of Physiology-Heart and Circulatory Physiology;320(4):H1440-1455.
    View at Publisher | View at Google Scholar
  50. Al-Naama LM, Hassan MA, Mehdi JK. (2015). Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar medical journal;2015(2):14.
    View at Publisher | View at Google Scholar
  51. Obeagu EI. Chromium VI: (2024). A Silent Aggressor in Sickle Cell Anemia Pathophysiology. Elite Journal of Haematology; 2 (3).:81-95.
    View at Publisher | View at Google Scholar
  52. Obeagu EI. (2024). Maximizing longevity: erythropoietin’s impact on sickle cell anemia survival rates. Annals of Medicine and Surgery:10-97.
    View at Publisher | View at Google Scholar
  53. Obeagu EI, Ubosi NI, Obeagu GU, Egba SI, Bluth MH. (2024). Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications. Medicine;103(2): e36898.
    View at Publisher | View at Google Scholar
  54. Obeagu EI, Ayogu EE, Anyanwu CN, Obeagu GU. (2024). Drug-Drug Interactions in the Management of Coexisting Sickle Cell Anemia and Diabetes. Elite Journal of Health Science;2(2):1-9.
    View at Publisher | View at Google Scholar
  55. Obeagu EI, Obeagu GU. (2024). Dual Management: Diabetes and Sickle Cell Anemia in Patient Care. Elite Journal of Medicine;2(1):47-56.
    View at Publisher | View at Google Scholar
  56. Wood KC, Hsu LL, Gladwin MT. (2008). Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free radical biology and medicine;44(8):1506-1528.
    View at Publisher | View at Google Scholar
  57. Tewari S, Brousse V, Piel FB, Menzel S, Rees DC. (2015). Environmental determinants of severity in sickle cell disease. Haematologica;100(9):1108.
    View at Publisher | View at Google Scholar

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad

Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.

img

Gomez Barriga Maria Dolores

The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.

img

Lin Shaw Chin

Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.

img

Maria Dolores Gomez Barriga

Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.

img

Dr Maria Dolores Gomez Barriga

Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.

img

Dr Maria Regina Penchyna Nieto

Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.

img

Dr Marcelo Flavio Gomes Jardim Filho

Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”

img

Zsuzsanna Bene

Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner

img

Dr Susan Weiner